articleAug 3, 2015Closed access

Idarucizumab for dabigatran reversal

ADAnna D. GarrettPPharmDBBcps

Abstract

No abstract available for this paper.

Citation impact

1,169
total citations
FWCI
194.49
Percentile
100%
References
2
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Medicine
  • Idarucizumab
  • Dabigatran
  • Pharmacy
  • Community pharmacy
  • Intensive care medicine
  • Community practice
  • Pharmacology
No related works found for this paper.